儿科呼吸体外生命支持治疗进展——《儿科呼吸体外生命支持适应证》解读

Treatment progress of pediatric respiratory extracorporeal life support:Interpretation of Indications for Pediatric Respiratory Extracorporeal Life Support

体外生命支持(ECLS)也称为体外膜氧合(ECMO),作为一种生命支持技术,提高了心肺功能衰竭危重患者的抢救成功率。根据体外生命支持组织(ELSO)登记报告,ECLS在儿童(30 d至18岁)呼吸衰竭中的应用人数不断增多,其中对于儿童呼吸衰竭时应用ECLS的指征尚无统一的标准,目前ELSO已推出儿科呼吸体外生命支持适应证,现就儿童呼吸体外生命支持指南做一解读。

Extracorporeal life support （ECLS）, also known as extracorporeal membrane oxygenation （ECMO）, has been used to treat critically ill patients with respiratory and cardiovascular failure. ECLS has been validated as a life-saving therapy, which improves the survival. According to Extracorporeal Life Support Organization Registry Report 2012, the number of pediatric patients （30 days to 18 years） supported for respiratory failure is increasing. Indications for pediatric respiratory extracorporeal life support are not clear before. Now ELSO has put forward the indications for pediatric respi- ratory extracorporeal life support, which is interpretated in the article.